{"pmid":32395258,"pmcid":"PMC7212509","title":"Low-tech solutions for the COVID-19 supply chain crisis.","text":["Low-tech solutions for the COVID-19 supply chain crisis.","A global effort is ongoing in the scientific community and in the maker movement, which focuses on creating devices and tinkering with them, to reverse-engineer commercial medical equipment and get it to healthcare workers. For these 'low-tech' solutions to have a real impact, it is important for them to coalesce around approved designs.","Nat Rev Mater","Armani, Andrea M","Hurt, Darrell E","Hwang, Darryl","McCarthy, Meghan C","Scholtz, Alexis","32395258"],"abstract":["A global effort is ongoing in the scientific community and in the maker movement, which focuses on creating devices and tinkering with them, to reverse-engineer commercial medical equipment and get it to healthcare workers. For these 'low-tech' solutions to have a real impact, it is important for them to coalesce around approved designs."],"journal":"Nat Rev Mater","authors":["Armani, Andrea M","Hurt, Darrell E","Hwang, Darryl","McCarthy, Meghan C","Scholtz, Alexis"],"date":"2020-05-13T11:00:00Z","year":2020,"_id":"32395258","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1038/s41578-020-0205-1","keywords":["business and industry","sars-cov-2","scientific community"],"topics":["Prevention"],"weight":1,"_version_":1666627828052918272,"score":9.490897,"similar":[{"pmid":32363133,"pmcid":"PMC7195610","title":"The Inadequacy of Regulatory Frameworks in Time of Crisis and in Low-Resource Settings: Personal Protective Equipment and COVID-19.","text":["The Inadequacy of Regulatory Frameworks in Time of Crisis and in Low-Resource Settings: Personal Protective Equipment and COVID-19.","COVID-19 pandemic is plaguing the world and representing the most significant stress test for many national healthcare systems and services, since their foundation. The supply-chain disruption and the unprecedented request for intensive care unit (ICU) beds have created in Europe conditions typical of low-resources settings. This generated a remarkable race to find solutions for the prevention, treatment and management of this disease which is involving a large amount of people. Every day, new Do-It-Yourself (DIY) solutions regarding personal protective equipment and medical devices populate social media feeds. Many companies (e.g., automotive or textile) are converting their traditional production to manufacture the most needed equipment (e.g., respirators, face shields, ventilators etc.). In this chaotic scenario, policy makers, international and national standards bodies, along with the World Health Organization (WHO) and scientific societies are making a joint effort to increase global awareness and knowledge about the importance of respecting the relevant requirements to guarantee appropriate quality and safety for patients and healthcare workers. Nonetheless, ordinary procedures for testing and certification are currently questioned and empowered with fast-track pathways in order to speed-up the deployment of new solutions for COVID-19. This paper shares critical reflections on the current regulatory framework for the certification of personal protective equipment. We hope that these reflections may help readers in navigating the framework of regulations, norms and international standards relevant for key personal protective equipment, sharing a subset of tests that should be deemed essential even in a period of crisis.","Health Technol (Berl)","Pecchia, Leandro","Piaggio, Davide","Maccaro, Alessia","Formisano, Claudio","Iadanza, Ernesto","32363133"],"abstract":["COVID-19 pandemic is plaguing the world and representing the most significant stress test for many national healthcare systems and services, since their foundation. The supply-chain disruption and the unprecedented request for intensive care unit (ICU) beds have created in Europe conditions typical of low-resources settings. This generated a remarkable race to find solutions for the prevention, treatment and management of this disease which is involving a large amount of people. Every day, new Do-It-Yourself (DIY) solutions regarding personal protective equipment and medical devices populate social media feeds. Many companies (e.g., automotive or textile) are converting their traditional production to manufacture the most needed equipment (e.g., respirators, face shields, ventilators etc.). In this chaotic scenario, policy makers, international and national standards bodies, along with the World Health Organization (WHO) and scientific societies are making a joint effort to increase global awareness and knowledge about the importance of respecting the relevant requirements to guarantee appropriate quality and safety for patients and healthcare workers. Nonetheless, ordinary procedures for testing and certification are currently questioned and empowered with fast-track pathways in order to speed-up the deployment of new solutions for COVID-19. This paper shares critical reflections on the current regulatory framework for the certification of personal protective equipment. We hope that these reflections may help readers in navigating the framework of regulations, norms and international standards relevant for key personal protective equipment, sharing a subset of tests that should be deemed essential even in a period of crisis."],"journal":"Health Technol (Berl)","authors":["Pecchia, Leandro","Piaggio, Davide","Maccaro, Alessia","Formisano, Claudio","Iadanza, Ernesto"],"date":"2020-05-05T11:00:00Z","year":2020,"_id":"32363133","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1007/s12553-020-00429-2","keywords":["ce marking","covid-19","face-shields","international standards","masks","personal protective equipment","visors"],"topics":["Prevention"],"weight":1,"_version_":1666138496088145921,"score":125.17292},{"pmid":32304970,"pmcid":"PMC7195029","title":"Challenges and solutions for addressing critical shortage of supply chain for personal and protective equipment (PPE) arising from Coronavirus disease (COVID19) pandemic - Case study from the Republic of Ireland.","text":["Challenges and solutions for addressing critical shortage of supply chain for personal and protective equipment (PPE) arising from Coronavirus disease (COVID19) pandemic - Case study from the Republic of Ireland.","Coronavirus (COVID-19) is highly infectious agent that causes fatal respiratory illnesses, which is of great global public health concern. Currently, there is no effective vaccine for tackling this COVID19 pandemic where disease countermeasures rely upon preventing or slowing person-to-person transmission. Specifically, there is increasing efforts to prevent or reduce transmission to front-line healthcare workers (HCW). However, there is growing international concern regarding the shortage in supply chain of critical one-time-use personal and protective equipment (PPE). PPE are heat sensitive and are not, by their manufacturer's design, intended for reprocessing. Most conventional sterilization technologies used in hospitals, or in terminal medical device sterilization providers, cannot effectively reprocess PPE due to the nature and severity of sterilization modalities. Contingency planning for PPE stock shortage is important. Solutions in the Republic of Ireland include use of smart communication channels to improve supply chain, bespoke production of PPE to meets gaps, along with least preferred option, use of sterilization or high-level disinfection for PPE reprocessing. Reprocessing PPE must consider material composition, functionality post treatment, along with appropriate disinfection. Following original manufacturer of PPE and regulatory guidance is important. Technologies deployed in the US, and for deployment in the Republic of Ireland, are eco-friendly, namely vaporised hydrogen peroxide (VH2O2), such as for filtering facepiece respirators and UV irradiation and High-level liquid disinfection (Actichlor+) is also been pursed in Ireland. Safeguarding supply chain of PPE will sustain vital healthcare provision and will help reduce mortality.","Sci Total Environ","Rowan, Neil J","Laffey, John G","32304970"],"abstract":["Coronavirus (COVID-19) is highly infectious agent that causes fatal respiratory illnesses, which is of great global public health concern. Currently, there is no effective vaccine for tackling this COVID19 pandemic where disease countermeasures rely upon preventing or slowing person-to-person transmission. Specifically, there is increasing efforts to prevent or reduce transmission to front-line healthcare workers (HCW). However, there is growing international concern regarding the shortage in supply chain of critical one-time-use personal and protective equipment (PPE). PPE are heat sensitive and are not, by their manufacturer's design, intended for reprocessing. Most conventional sterilization technologies used in hospitals, or in terminal medical device sterilization providers, cannot effectively reprocess PPE due to the nature and severity of sterilization modalities. Contingency planning for PPE stock shortage is important. Solutions in the Republic of Ireland include use of smart communication channels to improve supply chain, bespoke production of PPE to meets gaps, along with least preferred option, use of sterilization or high-level disinfection for PPE reprocessing. Reprocessing PPE must consider material composition, functionality post treatment, along with appropriate disinfection. Following original manufacturer of PPE and regulatory guidance is important. Technologies deployed in the US, and for deployment in the Republic of Ireland, are eco-friendly, namely vaporised hydrogen peroxide (VH2O2), such as for filtering facepiece respirators and UV irradiation and High-level liquid disinfection (Actichlor+) is also been pursed in Ireland. Safeguarding supply chain of PPE will sustain vital healthcare provision and will help reduce mortality."],"journal":"Sci Total Environ","authors":["Rowan, Neil J","Laffey, John G"],"date":"2020-04-19T11:00:00Z","year":2020,"_id":"32304970","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.scitotenv.2020.138532","keywords":["covid19","healthcare workers","ppe","resource utilization","sterilization","sustainability"],"locations":["US","Ireland"],"countries":["United States","Ireland"],"countries_codes":["USA|United States","IRL|Ireland"],"e_drugs":["Hydrogen Peroxide"],"topics":["Prevention"],"weight":1,"_version_":1666138491128381440,"score":105.87966},{"pmid":32341616,"pmcid":"PMC7182752","title":"Exploration of alternative supply chains and distributed manufacturing in response to COVID-19; a case study of medical face shields.","text":["Exploration of alternative supply chains and distributed manufacturing in response to COVID-19; a case study of medical face shields.","Quarantine conditions arising as a result of the coronavirus (COVID-19) have had a significant impact on global production-rates and supply chains. This has coincided with increased demands for medical and personal protective equipment such as face shields. Shortages have been particularly prevalent in western countries which typically rely upon global supply chains to obtain these types of device from low-cost economies. National calls for the repurposing of domestic mass-production facilities have the potential to meet medical requirements in coming weeks, however the immediate demand associated with the virus has led to the mobilisation of a diverse distributed workforce. Selection of appropriate manufacturing processes and underused supply chains is paramount to the success of these operations. A simplified medical face shield design is presented which repurposes an assortment of existing alternative supply chains. The device is easy to produce with minimal equipment and training. It is hoped that the methodology and approach presented is of use to the wider community at this critical time.","Mater Des","Shokrani, Alborz","Loukaides, Evripides G","Elias, Edward","Lunt, Alexander J G","32341616"],"abstract":["Quarantine conditions arising as a result of the coronavirus (COVID-19) have had a significant impact on global production-rates and supply chains. This has coincided with increased demands for medical and personal protective equipment such as face shields. Shortages have been particularly prevalent in western countries which typically rely upon global supply chains to obtain these types of device from low-cost economies. National calls for the repurposing of domestic mass-production facilities have the potential to meet medical requirements in coming weeks, however the immediate demand associated with the virus has led to the mobilisation of a diverse distributed workforce. Selection of appropriate manufacturing processes and underused supply chains is paramount to the success of these operations. A simplified medical face shield design is presented which repurposes an assortment of existing alternative supply chains. The device is easy to produce with minimal equipment and training. It is hoped that the methodology and approach presented is of use to the wider community at this critical time."],"journal":"Mater Des","authors":["Shokrani, Alborz","Loukaides, Evripides G","Elias, Edward","Lunt, Alexander J G"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32341616","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.matdes.2020.108749","keywords":["covid-19","distributed manufacturing","medical face shields","micro-supply chains","repurposed manufacture","simplified design"],"topics":["Prevention"],"weight":1,"_version_":1666138495104581632,"score":95.602806},{"pmid":32346676,"pmcid":"PMC7186933","title":"Crowdsourcing a crisis response for COVID-19 in oncology.","text":["Crowdsourcing a crisis response for COVID-19 in oncology.","Crowdsourcing efforts are currently underway to collect and analyze data from patients with cancer who are affected by the COVID-19 pandemic. These community-led initiatives will fill key knowledge gaps to tackle crucial clinical questions on the complexities of infection with the causative coronavirus SARS-Cov-2 in the large, heterogeneous group of vulnerable patients with cancer.","Nat Cancer","Desai, Aakash","Warner, Jeremy","Kuderer, Nicole","Thompson, Mike","Painter, Corrie","Lyman, Gary","Lopes, Gilberto","32346676"],"abstract":["Crowdsourcing efforts are currently underway to collect and analyze data from patients with cancer who are affected by the COVID-19 pandemic. These community-led initiatives will fill key knowledge gaps to tackle crucial clinical questions on the complexities of infection with the causative coronavirus SARS-Cov-2 in the large, heterogeneous group of vulnerable patients with cancer."],"journal":"Nat Cancer","authors":["Desai, Aakash","Warner, Jeremy","Kuderer, Nicole","Thompson, Mike","Painter, Corrie","Lyman, Gary","Lopes, Gilberto"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32346676","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1038/s43018-020-0065-z","keywords":["cancer","sars-cov-2","scientific community"],"topics":["Prevention"],"weight":1,"_version_":1666138494947295232,"score":90.13604},{"pmid":32467176,"title":"CONTROLS TO MINIMIZE DISRUPTION OF THE PHARMACEUTICAL SUPPLY CHAIN DURING THE COVID-19 PANDEMIC.","text":["CONTROLS TO MINIMIZE DISRUPTION OF THE PHARMACEUTICAL SUPPLY CHAIN DURING THE COVID-19 PANDEMIC.","This article reviews currently available scientific literature related to the epidemiology, infectivity, survival, and susceptibility to disinfectants of Coronaviruses, in the context of the controls established to meet Good Manufacturing Practice regulations and guidance, and the public health guidance issued specifically to combat the Covid-19 pandemic. The possible impact of the COVID-19 pandemic on the pharmaceutical supply chain is assessed and recommendations are listed for risk mitigation steps to minimize supply disruption to pharmaceutical drug products. Areas addressed include a brief history of the COVID-19 viral pandemic, a description of the virus, the regulatory response to the pandemic, the screening of employees, the persistence on inanimate surfaces, cleaning and disinfection of manufacturing facilities, use of GMP-mandated personal protective equipment to counter the spread of the disease, the role of air changes in viral clearance, approaches to risk assessment and mitigation. Biological medicinal products have a great record of safety, yet the cell cultures used for production can be susceptible to viruses, and contamination events have occurred. Studies on SARS-CoV-1 for its ability to replicate in various mammalian cell lines used for biopharmaceutical manufacturing suggest SARS-CoV-2 poses low risk and any contamination would be detected by currently used adventitious virus testing. The consequences of the potential virus exposure of manufacturing processes, as well as the effectiveness of mitigation efforts are discussed. The pharmaceutical supply chain is complex, traversing many geographies and companies that range from large multinationals to mid and small size operations. This paper recommends practices that can be adopted by all companies, irrespective of their size, geographic location, or position in the supply chain.","PDA J Pharm Sci Technol","Cundell, Anthony M","Guilfoyle, Dennis Edward","Kreil, T R","Sawant, Anil","32467176"],"abstract":["This article reviews currently available scientific literature related to the epidemiology, infectivity, survival, and susceptibility to disinfectants of Coronaviruses, in the context of the controls established to meet Good Manufacturing Practice regulations and guidance, and the public health guidance issued specifically to combat the Covid-19 pandemic. The possible impact of the COVID-19 pandemic on the pharmaceutical supply chain is assessed and recommendations are listed for risk mitigation steps to minimize supply disruption to pharmaceutical drug products. Areas addressed include a brief history of the COVID-19 viral pandemic, a description of the virus, the regulatory response to the pandemic, the screening of employees, the persistence on inanimate surfaces, cleaning and disinfection of manufacturing facilities, use of GMP-mandated personal protective equipment to counter the spread of the disease, the role of air changes in viral clearance, approaches to risk assessment and mitigation. Biological medicinal products have a great record of safety, yet the cell cultures used for production can be susceptible to viruses, and contamination events have occurred. Studies on SARS-CoV-1 for its ability to replicate in various mammalian cell lines used for biopharmaceutical manufacturing suggest SARS-CoV-2 poses low risk and any contamination would be detected by currently used adventitious virus testing. The consequences of the potential virus exposure of manufacturing processes, as well as the effectiveness of mitigation efforts are discussed. The pharmaceutical supply chain is complex, traversing many geographies and companies that range from large multinationals to mid and small size operations. This paper recommends practices that can be adopted by all companies, irrespective of their size, geographic location, or position in the supply chain."],"journal":"PDA J Pharm Sci Technol","authors":["Cundell, Anthony M","Guilfoyle, Dennis Edward","Kreil, T R","Sawant, Anil"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32467176","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.5731/pdajpst.2020.012021","keywords":["covid-19 pandemic","sars-cov-2","drug shortage","risk assessment","risk mitigation","supply chain"],"locations":["Coronaviruses","mammalian"],"e_drugs":["guanosine 5'-monophosphorothioate"],"topics":["Prevention"],"weight":1,"_version_":1668420887218487296,"score":87.5119}]}